ALXN.US
id: 822, Created by Stan Vick, Scout
Alexion (ALXN) $125M Shareholder Settlement
How it works?
- Company agreed to pay compensation to its investors, to avoid further litigation
- We help you to prepare documents and file for compensation
Claim payout
D. Connecticut
Court3:16-cv-2127
Case number30 Jan 2014
Class period Start26 May 2017
Class period EndAlexion (ALXN) agreed to settle a $125 million with shareholders to end claims that the $ALXN caused a double-digit plunge in stock price after its allegedly illegal sales strategy came to light.
Alleged Offence
Misleading Statements,
Failure to Disclose,
Omissions
Suspected Party
Directors,
Management
Security Type
Stocks
Trade Direction
Long
Payout per Share
0.76
Filing date
17 November 2016
Lead plaintiff
Boston Retirement System, David A. Slossberg, Jeffrey P. Nichols
Attorney
Labaton Sucharow LLP, Motley Rice LLC, Sturman LLC, Risch Pisca LLC
Defendants
Leonard Bell, David L. Hallal, Vikas Sinha
Judge
Hon. Alvin W. Thompson
Settlement agreement date
2023-09-13
Trades matching type
FIFO
+$125,000,000
Total Settlement AmountCase history
Stan Vick
16 September 2023
- Alexion shareholders asked approval from a federal judge in Connecticut for a $125 million settlement.
- This deal aims to resolve allegations that $ALXN allegedly illegal sales strategy led to a significant drop in stock price.
Stan Vick
18 September 2023
$ALXN case-related News:
In a New York federal court, a former vice president of Alexion Pharmaceuticals Inc. entered a guilty plea for informing a childhood friend about the $ALXN $1.4 billion acquisition of another biotech firm in 2020.